🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is a Phase Ib, randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00542464
Treatments Being Tested
Study BT-CL-PGG-CRC0821 is a Phase 2, open-label, multicenter, efficacy and...
Status
Completed
Location
University of Minnesota
Start Date
2009-06
Trial ID
NCT00912327
Treatments Being Tested
This study is a randomized, placebo-controlled, dose-escalation, single-cen...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00542529
Treatments Being Tested
The primary objective of this maintenance therapy study is to identify the ...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2022-12-15
Trial ID
NCT05484011
Treatments Being Tested
Objective: To determine the Overall Response Rate (ORR) to Imprime PGG + pe...
Status
Terminated
Location
Northwestern Medical Specialties, PLLC
Start Date
2017-11-08
Trial ID
NCT03246685
Treatments Being Tested
This Phase Ib dose escalation study will evaluate BTH1704, a monoclonal ant...
Status
Terminated
Location
UI Cancer Center
Start Date
2014-08
Trial ID
NCT02132403
Treatments Being Tested
The purpose of this trial is to the assess the safety, pharmacodynamics, an...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00542217
Treatments Being Tested
The Phase 2 study described in this protocol will serve to evaluate the ant...
Status
Completed
Location
Highlands Oncology Group
Start Date
2009-06
Trial ID
NCT00874107
Treatments Being Tested
Phase 1b, safety, pharmacokinetic, and efficacy, multicenter, dose-escalati...
Status
Completed
Location
Medical City
Start Date
2007-10
Trial ID
NCT00545545
Treatments Being Tested
The primary objective of this Phase 2 Simon 2-Stage study is to determinate...
Status
Completed
Location
The University of Arizona Cancer Center - North Campus
Start Date
2021-11-09
Trial ID
NCT05159778
Treatments Being Tested